You are here

hemophilia

BioMarin announces 'encouraging' early-stage hemophilia therapy data

Marketwatch

Wed, 04/20/16 - 09:37 am

Is Biogen Inc Setting Itself Up For an Acquisition?

Bidness, ETC

Tue, 04/12/16 - 08:30 am

Shire, Bayer Can Eye Biogen’s Hemophilia Assets For Acquisition

Bidness, ETC

Mon, 04/11/16 - 08:58 am

Biogen explores sale of hemophilia assets -sources

Yahoo/Reuters

Fri, 04/8/16 - 09:59 pm

Bayer sees its new Kovaltry as one arrow in a hemophilia quiver

Fierce Pharma Marketing

Wed, 02/24/16 - 09:52 pm

Hemophilia marketing tactics raise questions as market heats up

Fierce Pharma

Thu, 01/14/16 - 08:47 pm

Alnylam’s hemophilia drug appears to lower frequency of bleeding in early study

Bizjournals.com

Mon, 12/7/15 - 12:13 pm

Sanofi steps deeper into RNAi work, opts in on Alnylam hemophilia drug

Fierce Biotech

Fri, 10/2/15 - 04:53 pm

Here are the 5 drug classes with the biggest price gains

Fortune

Wed, 09/23/15 - 10:02 pm

compounded drugs

Biogen's Surprising Weakness

Motley Fool

Sat, 09/12/15 - 01:29 pm

What's The Street Think Of Alnylam Pharmaceuticals New Drug Data?

Yahoo/Benzinga

Thu, 06/25/15 - 09:03 am

Novo pumps up hemophilia drug production with $225M plant

Fierce Pharma

Mon, 05/4/15 - 11:28 am

drug manufacturing

Bayer pours $100M into Bay Area R&D with eyes on hemophilia

Fierce Pharma

Wed, 04/15/15 - 04:53 pm

Baxter's latest hemophilia drug comes through in Phase III

Fierce Biotech

Fri, 03/13/15 - 03:37 pm

Baxter International

Are These Biogen Idec's Next Blockbusters?

Investopedia

Tue, 03/10/15 - 08:10 am

Biogen Idec quietly carves out a leading role in developing gene therapy for hemophilia

Fierce Biotech

Thu, 01/29/15 - 09:41 am

Pfizer releases positive results from Phase III trial of BeneFIX to treat hemophilia B

Pharmaceutical Business Review

Sun, 07/20/14 - 09:31 am

Biogen prices new, long-acting hemophilia med with eye on patient-switching

Fierce Pharma Marketing

Wed, 07/9/14 - 05:15 pm

patient-switching

Hemophilia Drugs, Gambro Deal Boost Baxter's Growth

Investors.com

Fri, 07/4/14 - 11:48 am

Baxter International

Biogen Hemophilia Drugs Launch Into The Unknown

Investors.com

Mon, 06/30/14 - 05:53 pm

Pages